Stocks and Investing
Stocks and Investing
Tue, October 1, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Louise Chen Reiterated (zvra) at Buy on, Oct 1st, 2024
Published on 2024-10-28 14:34:08 - WOPRAI, Louise Chen
Louise Chen of Cantor Fitzgerald, Reiterated "Zevra Therapeutics, Inc." (ZVRA) at Buy on, Oct 1st, 2024.
Louise has made no other calls on ZVRA in the last 4 months.
There are 5 other peers that have a rating on ZVRA. Out of the 5 peers that are also analyzing ZVRA, 0 agree with Louise's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Louise
- Oren Livnat of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $20 on, Monday, September 30th, 2024
- Jason Butler of "JMP Securities" Initiated at Buy and Held Target at $17 on, Tuesday, September 24th, 2024
- Jason McCarthy of "Maxim Group" Maintained at Strong Buy with Increased Target to $25 on, Tuesday, September 24th, 2024
- Jonathan Aschoff of "Roth MKM" Maintained at Strong Buy with Increased Target to $21 on, Tuesday, September 24th, 2024
- Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $22 on, Wednesday, September 18th, 2024
Contributing Sources